{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:27:59Z","timestamp":1792672079019,"version":"4.5.0"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.2967\/jnumed.111.091439","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T13:01:31Z","timestamp":1315573291000},"page":"1541-1549","source":"Crossref","is-referenced-by-count":72,"title":["Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by <sup>18<\/sup>F-Fluoroestradiol PET"],"prefix":"10.2967","volume":"52","author":[{"given":"Brenda F.","family":"Kurland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanell M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Dunnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mankoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2011,9,8]]},"reference":[{"key":"2021051712022235000_52.10.1541.1","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.1996.14.7.2000","article-title":"Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group","volume":"14","author":"Buzdar","year":"1996","journal-title":"J Clin Oncol."},{"key":"2021051712022235000_52.10.1541.2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.1996.14.9.2584","article-title":"Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy","volume":"14","author":"Kuukasj\u00e4rvi","year":"1996","journal-title":"J Clin Oncol."},{"key":"2021051712022235000_52.10.1541.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1804"},{"key":"2021051712022235000_52.10.1541.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp427"},{"key":"2021051712022235000_52.10.1541.5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800215)45:4<792::AID-CNCR2820450430>3.0.CO;2-X"},{"key":"2021051712022235000_52.10.1541.6","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.12.2193"},{"key":"2021051712022235000_52.10.1541.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3034"},{"key":"2021051712022235000_52.10.1541.8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jcp.54.12.951","article-title":"Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma","volume":"54","author":"Douglas-Jones","year":"2001","journal-title":"J Clin Pathol."},{"key":"2021051712022235000_52.10.1541.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7245"},{"key":"2021051712022235000_52.10.1541.10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2645"},{"key":"2021051712022235000_52.10.1541.11","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2771"},{"key":"2021051712022235000_52.10.1541.12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.2"},{"key":"2021051712022235000_52.10.1541.13","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPD1AO3YSYQYNW"},{"key":"2021051712022235000_52.10.1541.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4082"},{"key":"2021051712022235000_52.10.1541.15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiology.169.1.3262228","article-title":"Breast cancer: PET imaging of estrogen receptors","volume":"169","author":"Mintun","year":"1988","journal-title":"Radiology."},{"key":"2021051712022235000_52.10.1541.16","first-page":"933","article-title":"Positron emission tomography with 2-[18F]Fluoro-2-deoxy-d-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy","volume":"2","author":"Mortimer","year":"1996","journal-title":"Clin Cancer Res."},{"key":"2021051712022235000_52.10.1541.17","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2001.19.11.2797","article-title":"Metabolic flare: indicator of hormone responsiveness in advanced breast cancer","volume":"19","author":"Mortimer","year":"2001","journal-title":"J Clin Oncol."},{"key":"2021051712022235000_52.10.1541.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3810"},{"key":"2021051712022235000_52.10.1541.19","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050359"},{"key":"2021051712022235000_52.10.1541.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(98)00098-5"},{"key":"2021051712022235000_52.10.1541.21","unstructured":"Peterson LM Kurland BF Link JM . Factors influencing the uptake of 18F-Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer. Nucl Med Biol. In press."},{"key":"2021051712022235000_52.10.1541.22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1981.tb01163.x","article-title":"Should clearance be normalised to body surface or to lean body mass?","volume":"11","author":"Hallynck","year":"1981","journal-title":"Br J Clin Pharmacol."},{"key":"2021051712022235000_52.10.1541.23","first-page":"235","article-title":"Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution","volume":"27","author":"Hamacher","year":"1986","journal-title":"J Nucl Med."},{"key":"2021051712022235000_52.10.1541.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.061044"},{"key":"2021051712022235000_52.10.1541.25","first-page":"1664","article-title":"The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors","volume":"41","author":"Thie","year":"2000","journal-title":"J Nucl Med."},{"key":"2021051712022235000_52.10.1541.26","doi-asserted-by":"publisher","DOI":"10.1137\/0915079"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.111.091439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:35:00Z","timestamp":1621280100000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.111.091439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,8]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,3]]},"published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.2967\/jnumed.111.091439"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.111.091439","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,8]]}}}